Eamonn Molloy

4.1k total citations
63 papers, 2.4k citations indexed

About

Eamonn Molloy is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Eamonn Molloy has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 16 papers in Rheumatology and 13 papers in Oncology. Recurrent topics in Eamonn Molloy's work include Vasculitis and related conditions (23 papers), Polyomavirus and related diseases (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Eamonn Molloy is often cited by papers focused on Vasculitis and related conditions (23 papers), Polyomavirus and related diseases (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Eamonn Molloy collaborates with scholars based in Ireland, United States and United Kingdom. Eamonn Molloy's co-authors include Leonard H. Calabrese, Géraldine McCarthy, Aneesh B. Singhal, Carol A. Langford, Rula A. Hajj‐Ali, Susanne M. Benseler, Richard Whittington, Richard M. Ransohoff, DeRen Huang and Lorraine O’Neill and has published in prestigious journals such as Stroke, The Lancet Neurology and Annals of the Rheumatic Diseases.

In The Last Decade

Eamonn Molloy

60 papers receiving 2.3k citations

Peers

Eamonn Molloy
Richard J. Wakefield United Kingdom
Mark Peterson United States
Hua He United States
Eva C. Guinan United States
John P. Curtin United States
Laura B. Pincus United States
Eamonn Molloy
Citations per year, relative to Eamonn Molloy Eamonn Molloy (= 1×) peers Андреас Каппелер

Countries citing papers authored by Eamonn Molloy

Since Specialization
Citations

This map shows the geographic impact of Eamonn Molloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eamonn Molloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eamonn Molloy more than expected).

Fields of papers citing papers by Eamonn Molloy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eamonn Molloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eamonn Molloy. The network helps show where Eamonn Molloy may publish in the future.

Co-authorship network of co-authors of Eamonn Molloy

This figure shows the co-authorship network connecting the top 25 collaborators of Eamonn Molloy. A scholar is included among the top collaborators of Eamonn Molloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eamonn Molloy. Eamonn Molloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, Arthur, Cathal Walsh, Louis J. M. Aslett, et al.. (2022). Extended data for 'ANCA-associated vasculitis in Ireland: a multi-centre national cohort study'. Zenodo (CERN European Organization for Nuclear Research).
2.
Cid, María C., Sebastian Unizony, Daniël Blockmans, et al.. (2022). Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases. 81(5). 653–661. 82 indexed citations
3.
Murray, Kieran, Louise Moore, Caroline Brophy, et al.. (2018). Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelines. Irish Journal of Medical Science (1971 -). 188(1). 169–172. 11 indexed citations
4.
O’Neill, Lorraine & Eamonn Molloy. (2016). The role of toll like receptors in giant cell arteritis. Lara D. Veeken. 55(11). 1921–1931. 22 indexed citations
5.
Calabrese, Leonard H., Eamonn Molloy, & Joseph R. Berger. (2014). Sorting out the risks in progressive multifocal leukoencephalopathy. Nature Reviews Rheumatology. 11(2). 119–123. 36 indexed citations
6.
Flyvbjerg, Bent & Eamonn Molloy. (2011). Delusion, Deception and Corruption in Major Infrastructure Projects: Causes, Consequences and Cures. Chapters. 8 indexed citations
7.
Hajj‐Ali, Rula A., Aneesh B. Singhal, Susanne M. Benseler, Eamonn Molloy, & Leonard H. Calabrese. (2011). Primary angiitis of the CNS. The Lancet Neurology. 10(6). 561–572. 223 indexed citations
8.
Molloy, Eamonn. (2011). PML and rheumatology: The contribution of disease and drugs. Cleveland Clinic Journal of Medicine. 78(11 suppl 2). S28–S32. 18 indexed citations
9.
Molloy, Eamonn & Leonard H. Calabrese. (2009). Progressive multifocal leukoencephalopathy: A national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis & Rheumatism. 60(12). 3761–3765. 159 indexed citations
10.
Doherty, Glen, Eamonn Molloy, Sandra Austin, et al.. (2009). Proneoplastic effects of PGE2mediated by EP4 receptor in colorectal cancer. BMC Cancer. 9(1). 207–207. 54 indexed citations
11.
Molloy, Eamonn, Maria P. Morgan, Glen Doherty, et al.. (2008). Mechanism of basic calcium phosphate crystal-stimulated cyclo-oxygenase-1 up-regulation in osteoarthritic synovial fibroblasts. Lara D. Veeken. 47(7). 965–971. 16 indexed citations
12.
Molloy, Eamonn & Leonard H. Calabrese. (2008). Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: Are patients with systemic lupus erythematosus at particular risk?. Autoimmunity Reviews. 8(2). 144–146. 96 indexed citations
13.
Calabrese, Leonard H. & Eamonn Molloy. (2008). Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Annals of the Rheumatic Diseases. 67. iii64–iii65. 77 indexed citations
14.
Molloy, Eamonn, Maria P. Morgan, Glen Doherty, et al.. (2008). Microsomal prostaglandin E2 synthase 1 expression in basic calcium phosphate crystal-stimulated fibroblasts: role of prostaglandin E2 and the EP4 receptor. Osteoarthritis and Cartilage. 17(5). 686–692. 10 indexed citations
15.
Calabrese, Leonard H., Eamonn Molloy, DeRen Huang, & Richard M. Ransohoff. (2007). Progressive multifocal leukoencephalopathy in rheumatic diseases: Evolving clinical and pathologic patterns of disease. Arthritis & Rheumatism. 56(7). 2116–2128. 143 indexed citations
16.
Molloy, Eamonn, et al.. (2006). BCP crystals increase prostacyclin production and upregulate the prostacyclin receptor in OA synovial fibroblasts: potential effects on mPGES1 and MMP-13. Osteoarthritis and Cartilage. 15(4). 414–420. 15 indexed citations
17.
Molloy, Eamonn & Géraldine McCarthy. (2006). Basic calcium phosphate crystals: pathways to joint degeneration. Current Opinion in Rheumatology. 18(2). 187–192. 19 indexed citations
18.
Molloy, Eamonn & Géraldine McCarthy. (2004). How crystals damage tissue. Current Rheumatology Reports. 6(3). 228–234. 13 indexed citations
19.
Molloy, Eamonn & Géraldine McCarthy. (2003). Hydroxyapatite deposition disease of the joint. Current Rheumatology Reports. 5(3). 215–221. 20 indexed citations
20.
Molloy, Eamonn & Seán F. Dinneen. (2000). 55-Year-Old Woman With Worsening Seizure Control. Mayo Clinic Proceedings. 75(5). 529–532.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026